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Abstract:  
Dopamine of renal origin has natriuretic/diuretic actions by activating D1-like receptors of the 
nephron. Saline load increases renal dopamine production and natriuresis in healthy subjects, and, 
under these conditions, the activation of D2-like receptors also produces natriuresis/diuresis. 
Metoclopramide is a D2-like receptor antagonist. Patients with heart failure (HF) have an increased 
renal dopamine-synthesizing efficiency. However, the effect of salt loading was not explored in HF. 
We hypothesized that HF patients respond to salt loading with increased production of renal 
dopamine and that metoclopramide antagonizes this response. This was a randomized, controlled, 
crossover study exploring the effect of NaCl and metoclopramide on renal dopaminergic, 
sympathetic, renin-angiotensin-aldosterone, and arginine-vasopressin (AVP) systems activity on 
sodium handling in 9 HF patients and 9 controls. NaCl markedly increased renal dopamine 
production and natriuresis in both groups. Metoclopramide blunted these responses in HF patients 
but not in controls. NaCl decreased renin and aldosterone plasma levels in controls but not in HF 
patients. In these patients B-type natriuretic peptide (BNP) levels increased, but AVP was not 
affected. HF patients respond to salt loading with increased natriuresis. However, the mechanisms 
for this response are different from those found in healthy subjects. Metoclopramide has 
antinatriuretic effects only in HF patients.  
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